Product NewsClinical Diagnostics Oxford Immunotec and Lophius Biosciences Sign Licensing and Collaboration Agreement
Product NewsClinical Diagnostics Study results confirm ability of T-SPOT®.TB to detect tuberculosis disease in HIV infected patients
Product NewsClinical Diagnostics Study results confirm higher sensitivity of T-SPOT.TB in immunosuppressed patient groups
Product NewsDrug discovery > Lead Discovery Oxford Immunotec’s T-SPOT.TB is first test to demonstrate accurate diagnosis of latent TB in HIV patients
Product NewsOxford Immunotec announces launch of second generation product based on co- development with Millipore
